¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"respiratory reduction"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • reduction rhinoplasty
    ÄÚÃà¼Ò(¼ú), Ãà¼ÒÄÚ¼ºÇü(¼ú)
  • scalp reduction
    ¸Ó¸®µ¤°³Ãà¼Ò(¼ú), µÎÇÇÃà¼Ò(¼ú)
  • stress-reduction technique
    ½ºÆ®·¹½º°¨¼Ò±â¹ý
  • silver reduction method
    ÀºÈ¯¿ø¹ý
  • acute respiratory distress syndrome
    ±Þ¼ºÈ£Èí°ï¶õÁõÈıº
  • adult respiratory distress syndrome
    ¼ºÀÎÈ£Èí°ï¶õÁõÈıº
  • hypoxemic respiratory failure
    Àú»ê¼ÒÇ÷ÁõÈ£Èí±â´É»ó½Ç, Àú»ê¼ÒÇ÷ÁõÈ£ÈíºÎÀü
  • idiopathic respiratory distress
    Ư¹ßÈ£Èí°ï¶õ
  • idiopathic respiratory distress syndrome
    Ư¹ßÈ£Èí°ï¶õÁõÈıº
  • medullary respiratory center
    ¼û³úÈ£ÈíÁßÃß, ¿¬¼öÈ£ÈíÁßÃß
  • medullary respiratory chemoreceptor
    ¼û³úÈ£ÈíÈ­Çмö¿ëü
  • nonprotein respiratory quotient
    ºñ´Ü¹éÁúÈ£ÈíÁö¼ö
  • respiratory
    1. È£Èí- 2. È£Èí¼º-
  • respiratory acidosis
    È£Èí¼º»êÁõ
  • respiratory alkalosis
    È£Èí¼º¾ËÄ®¸®Áõ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • respiratory failure
    È£Èí±â´É»ó½Ç, È£ÈíºÎÀü
  • respiratory gating
    È£Èíµ¿±â
  • respiratory insufficiency
    È£Èí±â´ÉºÎÁ·
  • respiratory mucosa
    È£ÈíÁ¡¸·
  • respiratory nerve
    È£Èí½Å°æ
  • respiratory organ
    È£Èí±â°ü
  • respiratory obstruction
    ±âµµ¸·Èû, È£ÈíÆó¼â
  • respiratory quotient
    È£ÈíÁö¼ö, È£Èí»ó¼ö
  • respiratory rate
    È£Èí¼öÈ£Èí·ü
  • respiratory substrate
    È£Èí±âÁú
  • respiratory system
    È£Èí°èÅë
  • respiratory stimulant
    È£ÈíÀÚ±ØÁ¦
  • respiratory stenosis
    ±âµµÇùÂø(Áõ)
  • respiratory standstill
    È£ÈíÁ¤Áö
  • respiratory distress syndrome
    È£Èí°ï¶õÁõÈıº
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • reduction
    ±³Á¤, ȯ¿ø, Ãà¼Ò
  • reduction rhinoplasty
    ÄÚÃà¼Ò¼ú, Ãà¼ÒÄÚ¼ºÇü¼ú
  • reduction semiconductor
    ȯ¿øÇü¹ÝµµÃ¼
  • reduction test
    ȯ¿ø½ÃÇè
  • scalp reduction
    ¸Ó¸®µ¤°³Ãà¼Ò¼ú, µÎÇÇÃà¼Ò¼ú
  • stress-reduction technique
    ½ºÆ®·¹½º°¨¼Ò±â¹ý
  • respiratory acidosis
    È£Èí»êÁõ
  • respiratory alkalosis
    È£Èí¾ËÄ«¸®Áõ
  • respiratory apparatus
    È£Èí±â°ü
  • respiratory arrest
    È£ÈíÁ¤Áö
  • respiratory arrhythmia
    È£ÈíºÎÁ¤¸Æ
  • respiratory bag
    È£ÈíÁÖ¸Ó´Ï
  • respiratory bronchiole
    È£Èí¼¼±â°üÁö
  • respiratory burst
    È£ÈíÅÍÁü
  • medullary respiratory center
    ¼û³úÈ£ÈíÁßÃß, ¿¬¼öÈ£ÈíÁßÃß
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • idiopathic respiratory distress of newborn infant =IRDNI
    ½Å»ý¾ÆÆ¯¹ß¼º È£Èí°ï¶õÁõ.
  • idiopathic respiratory distress syndrome
    Ư¹ß¼º È£Èí°ï¶õÁõÈıº.
  • plaque reduction neutralization test
    ÇöóÅ© °¨¼ÒÁßÈ­½ÃÇè
  • plaque reduction test
    ÇöóÅ© °¨¼Ò½ÃÇè
  • pock reduction test
    Æø °¨¼ÒÁßÈ­½ÃÇè
  • pontine respiratory center
    ³ú±³È£ÈíÁßÃß(ÒàÎéû¼ýåñéõÒ).
  • rds=£¾respiratory distress syndrome
    È£Èí°ï¶õÁõÈıº(û¼ýåÍÝÑññøý¦ÏØ)
  • reduction
    Á¤º¹¼ú, °¨¼Ò, Ãà¼Ò
  • reduction
    ȯ¿ø(ü½êª), °¨¼Ò.
  • reduction
    Á¤º¹, °¨¼Ò
  • reduction discharge
    ȯ¿ø¼º¹æ.
  • reduction division
    °¨¼öºÐ¿­(Êõâ¦ÝÂæñ).
  • reduction division
    °¨¼öºÐ¿­
  • reduction division
    °¨¼öºÐ¿­
  • reduction in area
    ´Ü¸é¼öÃà·ü(Ó¨Øüâ¥õêëÒ).
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • proportional reduction
    ºñ·Ê°¨·Â(ÝïçÓÊõæ³).
  • reduction
    Á¤º¹¼ú, °¨¼Ò, Ãà¼Ò
  • reduction
    Á¤º¹, °¨¼Ò
  • reduction
    ȯ¿ø(ü½êª), °¨¼Ò.
  • reduction discharge
    ȯ¿ø¼º¹æ.
  • reduction division
    °¨¼öºÐ¿­
  • reduction division
    °¨¼öºÐ¿­(Êõâ¦ÝÂæñ).
  • reduction division
    °¨¼öºÐ¿­
  • reduction in area
    ´Ü¸é¼öÃà·ü(Ó¨Øüâ¥õêëÒ).
  • reduction of cardiac work load
    ½ÉÀÛ¾÷·®ÀÇ °æ°¨(ãýíÂåöåÖ¡­ÌîÊõ).
  • reduction of chromosome
    ¿°»öü°¨¼ö(æøßäô÷Êõâ¦).
  • reduction of fraction
    ¾àºÐ(å³ÝÂ).
  • reduction of fracture
    °ñÀý Á¤º¹(Íéï¹ïÚÜÖ).
  • reduction potential
    ȯ¿øÀüÀ§.
  • reduction rhinoplasty
    Ãà¼Òºñ¼ºÇü¼ú
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • sulfate reduction
    Ȳ»êȯ¿ø(üÜß«ü½êª)
  • nonprotein respiratory quotient
    ºñ´Ü¹éÁú È£Èí»ó(ÞªÓ±ÛÜòõ û¼ýåßÂ)
  • respiratory acidosis
    È£Èí»êÁõ(û¼ýåß«ñø)
  • respiratory alkalosis
    È£Èì¾ËÄ®¸®Áõ(ñø)
  • respiratory assembly
    È£Èí ¾Æ
  • respiratory burst
    È£Èí ±ÞÁõ(Ðáñø)
  • respiratory chain
    È£Èí ¿¬¼â(Ö§áð)
  • respiratory chain phosphorylation
    È£Èí¿¬¼â ÀλêÈ­(×òß«ûù)
  • respiratory complex
    È£Èí º¹ÇÕü(ÜÜùêô÷)
  • respiratory control
    È£Èí Á¶Àý(ðàï½)
  • respiratory-control index
    È£Èí Á¶Àý Áö¼ö(ò¦â¦)
  • respiratory enzyme
    È£Èí È¿¼Ò(ý£áÈ)
  • respiratory enzyme complex
    È£Èí È¿¼Ò º¹ÇÕü(ÜÜùêô÷)
  • respiratory inhibitor
    È£Èí ÀúÇØÁ¦(îÁúªð¥)
  • respiratory pigment
    È£Èí »ö¼Ò(ßäáÈ)
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 11 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • respiratory failure
    È£ÈíºÎÀü
  • respiratory function
    È£Èí±â´É
  • respiratory function test
    È£Èí±â´É°Ë»ç
  • respiratory gating
    È£Èíµ¿±â
  • respiratory insufficiency
    È£Èí(±â´É)ºÎÀü
  • respiratory obstruction
    ±âµµÆó¼â, È£ÈíÆó¼â
  • respiratory ordered phase encoding
    È£Èí¼øÀ§»óºÎȣȭ
  • respiratory organ
    È£Èí±â
  • respiratory paralysis
    È£Èí¸¶ºñ
  • respiratory tract
    ±âµµ, È£Èí±âµµ
  • respiratory volume
    È£Èí¿ëÀû
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
CRD carbohydrate-recognition domain; chronic renal disease; chronic respiratory disease; child restraint...
IRDS idiopathic respiratory distress syndrome; infant respiratory distress syndrome
LRI lamina rara interna; lower respiratory [tract] illness; lower respiratory [tract] infection; lymphoc...
LRTI lower respiratory tract illness; lower respiratory tract infection
MRV minute respiratory volume; mixed respiratory vaccine
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
LRD Limb reduction defects
LVRS Lung Volume Reduction Surgery
LVR Lung volume reduction
MFPR Multifetal pregnancy reduction
ORIF Open reduction and internal fixation
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • adult respiratory distress syndrome
    ¼ºÀμº È£Èí°ï¶õ ÁõÈıº
    ¿Ü»ó ¸çÄ¥ ÈÄ¿¡ ¹ß»ýÇÏ´Â °©ÀÛ½º·¯¿î Æó °£Áú ¹× ÆóÆ÷ÀÇ ºÎÁ¾. ÀÌ´Â ³ú ¼Õ»ó ȤÀº Àú»ê¼ÒÁõ¿¡ ÀÇÇØ »ý±â´Â °ú°ÝÇÑ ±³°¨½Å°æ°è Ç×Áø ¶Ç´Â ¸ð¼¼Ç÷°ü Åõ°ú¼ºÀÇ Áõ°¡°¡ ¿øÀÎÀ¸·Î »ý°¢µÈ´Ù.
  • allergic respiratory disease
    ¾Ë·¹¸£±â¼º È£Èí±âº´
  • non-respiratory acidosis
    ºñÈ£Èí¼º »êÁõ
  • non-respiratory depressant drug
    ºñ-È£Èí ¾ïÁ¦Á¦
  • nonprotein respiratory quotient
    ºñ´Ü¹é È£Èí»ó
  • respiratory acidosis
    È£Èí¼º »êÁõ
    1. ÀÌ»êȭź¼Ò ºÐ¾ÐÀÇ Áõ°¡·Î »êµµ¿Í ¼ö¼Ò ÀÌ¿ÂÀÇ ³óµµ°¡ Áõ°¡Çϰí Áßź»ê¿°ÀÌ Áõ°¡ÇÑ´Ù. 2. °¨¼ÒµÈ ÆóÆ÷ ȯ±â¿Í µÚÀÌÀº °íź»êÇ÷ÁõÀ¸·ÎºÎÅÍ ³ª¿Â´Ù. È£Èí±â Áúȯ»Ó¸¸ ¾Æ´Ï¶ó ºñÈ£Èí±â Áúȯµµ Àúȯ±â¸¦ À¯¹ßÇÒ ¼ö ÀÖ´Ù. ÀÓ»ó°¡µéÀº ÈçÈ÷ ÃÖ¸éÁ¦·Î ÀÎÇÑ ÁßÃß ½Å°æ ¾ïÁ¦ ¶§¹®¿¡ »ý±â´Â È£Èí¼º »êÁõ°ú °°ÀÌ °¡¿ªÀûÀÎ ¿øÀο¡ ´ëÇØ ¹Ýµå½Ã »ó±âÇϰí ÀÖ¾î¾ß ÇÑ´Ù. ±Þ¼º È£Èí ºÎÀüÀº ½ÉÇÑ »êÁõ°ú Ç÷û Áßź»ê ÀÌ¿ÂÀÇ ¹Ì¹ÌÇÑ Áõ°¡¿Í ¿¬°üµÇ¾î ÀÖ´Ù. 6-12½Ã°£ µÚ¿¡ ÀÌ»êȭź¼Ò ºÐ¾ÐÀÇ ÀÏÂ÷ÀûÀÎ Áõ°¡°¡ ½ÅÀåÀÇ º¸»ó ¹ÝÀÀÀ» À¯¹ßÇÏ¿© ´õ ¸¹Àº ź»ê¿°À» ¸¸µé¾î ³»°í À̴ ȣÈí¼º »êÁõÀ» °³¼±½ÃŲ´Ù. º¸Åë ÀÌ ÀÛ¿ëÀ» ¿ÏÀüÈ÷ ÇÏ´Â µ¥ ¼ö ÀÏ °É¸°´Ù.
  • respiratory arrest
    È£Èí Á¤Áö
    µ¿ÀǾî=res
  • respiratory bag
    È£Èí ³¶
  • respiratory bronchiolitis
    È£Èí ¼¼±â°üÁö¿°
    ÀþÀº Èí¿¬°¡¿¡¼­ º¼ ¼ö ÀÖ´Â ¼Ò±âµµ ÁúȯÀÌ´Ù. ÀÓ»óÀûÀ¸·Î³ª ¹æ»ç¼± »çÁø»ó Ư¹ß¼º °£Áú¼º Æó ¼¶À¯È­Áõ°ú À¯»çÇÏ´Ù. ±âħ, È£Èí °ï¶õ, ûÁø»ó ¼öÆ÷À½ µîÀÌ Æ¯Â¡ÀÌ´Ù. Ư¹ß¼º °£Áú¼º Æó ¼¶À¯È­Áõ¿¡¼­ º¸ÀÌ´Â ÆóÀ¯¼øµµÀÇ °¨¼Ò´Â ÀÌ Áúȯ¿¡¼­´Â º¼ ¼ö ¾øÀ¸¸ç, °£È¤ °³Èä Æó »ý°Ë¿¡¼­ ¹ß°ßµÇ´Âµ¥ Á¶Á÷ °Ë»ç»ó ¸»´Ü ¼¼±â°üÁö¿Í È£Èí ¼¼±â°üÁö¿¡ Ư¡ÀûÀÎ ÀÌÇü¼º°ú »ö¼Ò Ä§Âø ¼¼Æ÷, ´ë½Ä ¼¼Æ÷¿¡ ÀÇÇÑ ÆóÆ÷, ÆóÆ÷°ü, ¸»´Ü ¹× È£Èí ¼¼±â°üÁöÀÇ ±âµµ ÃæÀüÀ» º¼ ¼ö ÀÖ´Ù.
  • respiratory center
    È£Èí ÁßÃß
  • respiratory dead space
    È£Èí¼º ¹«È¿ °ø°£
  • respiratory depression
    È£Èí ÀúÇÏ
  • respiratory distress syndrome
    È£Èí °ï¶õ ÁõÈıº
  • respiratory disturbance
    È£Èí Àå¾Ö
  • respiratory excitant
    È£Èí ÈïºÐ ¾à
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
Schmorl's ferric-ferricyanide reduction stain <technique> A stain to test for reducing substances in tissues, including melanin, argentaffin granules, thyroid colloid, keratin, keratohyalin, and lipofuscin pigments; ferricyanide is converted into ferrocyanide which is converted to insoluble Prussian blue in the presence of ferric ions.
(05 Mar 2000)
selective reduction <obstetrics> A technique for intrauterine termination of one or more foetuses while leaving one or more foetuses undisturbed, usually in pregnancies with foetal anomalies or with multiple gestations.
(05 Mar 2000)
source emission reduction plan (SERP) A contingency plan developed to reduce emissions during an air quality emergency.
(05 Dec 1998)
nitroblue tetrazolium reduction <chemical> Nitroblue tetrazolium, a yellow dye, is taken up by phagocytosing neutrophils and reduced to insoluble formazan, which is deep blue, if the metabolic burst is normal. Reduction does not take place in chronic granulomatous disease.
(18 Nov 1997)
internal reduction The relocation of a joint or realignment of a fracture through a surgical incision. most internal reductions utilise general anaesthesia.
(27 Sep 1997)
open reduction of fractures Reduction by manipulation of bone, after incision in skin and muscle over the site of the fracture.
(05 Mar 2000)
oxidation-reduction A chemical reaction in which an electron is transferred from one molecule to another. The electron-donating molecule is the reducing agent or reductant; the electron-accepting molecule is the oxidizing agent or oxidant. Reducing and oxidizing agents function as conjugate reductant-oxidant pairs or redox pairs.
(12 Dec 1998)
oxidation-reduction electrode An electrode capable of measuring oxidation-reduction potential.
See: quinhydrone electrode.
Synonym: redox electrode.
(05 Mar 2000)
oxidation-reduction indicator A substance that undergoes a definite colour change at a specific oxidation potential.
Synonym: redox indicator.
(05 Mar 2000)
oxidation-reduction potential <chemistry, physics> The potential in volts of an inert metallic electrode measured in a system of an arbitrarily chosen ratio of [oxidant] to [reductant] and referred to the normal hydrogen electrode at absolute temperature.
It is calculated from the following equation: where R is the gas constant expressed in electrical units, T the absolute temperature (Kelvin), n the number of electrons transferred, F the faraday and E0 the normal symbol for the potential of the system at pH 0; for biological systems E0' is often used (in which pH = 7).
Compare: Nernst's equation.
Synonym: redox potential.
(05 Mar 2000)
oxidation-reduction reaction <chemistry> Any reaction in which electrons are removed from one molecule or atom and given to another molecule or atom.
(09 Oct 1997)
oxidation-reduction system <enzyme> An enzyme system in the tissues by which oxidation and reduction proceed simultaneously through the transference of hydrogen or of one or more electrons from one metabolite to another.
See: oxidation-reduction.
Synonym: redox system.
(05 Mar 2000)
tuberosity reduction The surgical excision of excessive fibrous or bony tissue in the area of the maxillary tuberosity prior to the construction of prosthetic appliances.
(05 Mar 2000)
acute respiratory failure Loss of pulmonary function either acute or chronic that results in hypoxaemia or hypercarbia.
(05 Mar 2000)
adult respiratory distress syndrome <chest medicine, syndrome> A clinical syndrome that includes pulmonary insufficiency. It is a descriptive term that is applied to a variety of diffuse infiltrative processes in the lung.
Manifestations include severe shortness of breath, rapid breathing and arterial hypoxaemia (low oxygen). Chest X-ray shows bilateral diffuse infiltrates.
Treatment most often includes mechanical respiratory support. Causes include toxic gas (chlorine, NO2, smoke) exposure, severe metabolic derangement, gastric acid aspiration, pancreatitis, sepsis and trauma.
Acronym: ARDS
(12 Jul 2000)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
ÅëÇÕ°Ë»ö ¿Ï·á